These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 21380926)
1. The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line. Zhang YY; Xie KM; Yang GQ; Mu HJ; Yin Y; Zhang B; Xie P Int J Hematol; 2011 Mar; 93(3):361-367. PubMed ID: 21380926 [TBL] [Abstract][Full Text] [Related]
2. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi). Zhang X; Li J; Qiu Z; Gao P; Wu X; Zhou G Cancer Biol Ther; 2009 Jun; 8(12):1117-21. PubMed ID: 19502811 [TBL] [Abstract][Full Text] [Related]
3. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line. Liu Y; Xie KM; Yang GQ; Bai XM; Shi YP; Mu HJ; Qiao WZ; Zhang B; Xie P Cancer Chemother Pharmacol; 2010 Aug; 66(3):433-9. PubMed ID: 19936984 [TBL] [Abstract][Full Text] [Related]
4. [Study on the correlation of GCS and MDR1 genes in inducing multidrug resistance in human K562/A02 cell line]. Yang GQ; Xie KM; Liu Y; Mu HJ; Qiao WZ; Zhang B; Xie P Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):299-304. PubMed ID: 20533270 [TBL] [Abstract][Full Text] [Related]
5. Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells. Chen BA; Mao PP; Cheng J; Gao F; Xia GH; Xu WL; Shen HL; Ding JH; Gao C; Sun Q; Chen WJ; Chen NN; Liu LJ; Li XM; Wang XM Int J Nanomedicine; 2010 Aug; 5():437-44. PubMed ID: 20957165 [TBL] [Abstract][Full Text] [Related]
6. [NF-Îș B mediates the effect of glucosylceramide synthase on P-glycoprotein modulation in a drug-resistance leukemia cell line]. Zhang X; Xie K; Zou J; Li Y; Mu H; Zhang B; Xie P Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):34-8. PubMed ID: 24510559 [TBL] [Abstract][Full Text] [Related]
7. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling. Liu YY; Gupta V; Patwardhan GA; Bhinge K; Zhao Y; Bao J; Mehendale H; Cabot MC; Li YT; Jazwinski SM Mol Cancer; 2010 Jun; 9():145. PubMed ID: 20540746 [TBL] [Abstract][Full Text] [Related]
8. Glucosylceramide synthase promotes Bcl-2 expression via the ERK signaling pathway in the K562/A02 leukemia drug-resistant cell line. Wang Q; Zou J; Zhang X; Mu H; Yin Y; Xie P Int J Hematol; 2014 Dec; 100(6):559-66. PubMed ID: 25281403 [TBL] [Abstract][Full Text] [Related]
9. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells. Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283 [TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1. Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441 [TBL] [Abstract][Full Text] [Related]
11. [Reversal of multidrug resistance by MDR1 shRNA expression vector in human leukemia K562/A02 cells]. Xiao XB; Xie ZX; Qin Q Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):422-5. PubMed ID: 17152486 [TBL] [Abstract][Full Text] [Related]
12. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells. Chen JR; Jia XH; Wang H; Yi YJ; Li YJ Oncol Rep; 2017 May; 37(5):2735-2742. PubMed ID: 28358418 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of WT1/+17AA gene expression using RNAi and modulating leukemia cell chemotherapy resistance. Shen H; Xu W; Wu Z; Tang H; Xie Y; Zhong X Haematologica; 2007 Sep; 92(9):1270-2. PubMed ID: 17768125 [TBL] [Abstract][Full Text] [Related]
14. Reversion of P-glycoprotein-mediated multidrug resistance in human leukemic cell line by carnosic acid. Yu XN; Chen XL; Li H; Li XX; Li HQ; Jin WR Chin J Physiol; 2008 Dec; 51(6):348-56. PubMed ID: 19280878 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells. Xie P; Shen YF; Shi YP; Ge SM; Gu ZH; Wang J; Mu HJ; Zhang B; Qiao WZ; Xie KM Leuk Res; 2008 Mar; 32(3):475-80. PubMed ID: 17709137 [TBL] [Abstract][Full Text] [Related]
16. [siRNA silences mdr1 gene expression and reverses apoptosis resistance of K562/ADM cells line]. Wei HL; Gao LP; Jing T; Zhao HS; Yi J; Sun J; Han J Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):388-90. PubMed ID: 17939404 [TBL] [Abstract][Full Text] [Related]
17. Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription. Shen H; Xu W; Chen Q; Wu Z; Tang H; Wang F J Cancer Res Clin Oncol; 2010 May; 136(5):659-65. PubMed ID: 19898868 [TBL] [Abstract][Full Text] [Related]
18. Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro. Pan GD; Yang JQ; Yan LN; Chu GP; Liu Q; Xiao Y; Yuan L World J Gastroenterol; 2009 Jan; 15(4):431-40. PubMed ID: 19152447 [TBL] [Abstract][Full Text] [Related]
19. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line. Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731 [TBL] [Abstract][Full Text] [Related]
20. [Effect of glucosylceramide synthase on P-gp expression by ERK signal transduction pathway in leukemia multi-drug resistance cell line]. Li YL; Xie KM; Zhang YY; Mu HJ; Zhang B; Zou J; Xie P Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):270-4. PubMed ID: 22678786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]